Scientist pipetting onto a microscope slide

Bringing dencatistat to the clinic as fast as possible

Experienced drug developers and an international investor syndicate, with more than 50 years of collective experience in cancer treatments.

Leadership team

Saint-Genis-Pouilly and Paris
Andrew Parker
Andrew ParkerChief Executive Officer
Duc Tran
Duc TranChief Development Officer
Nicolas Marsault
Nicolas MarsaultChief Financial Officer
Philip Beer
Philip BeerChief Scientific Officer
Dr Karen Smith
Dr Karen SmithChief Medical Officer
Maureen Higgins
Maureen HigginsVP, Head of Clinical Operations

Board and investors

€38M Series C, October 2025

The Series C, led by V-Bio Ventures, funds clinical proof-of-concept studies for dencatistat. An EIC grant of €2.5M supports work in CTPS2-null gynaecological cancers.

Scientific founder Prof. Alain Fischer is an internationally recognised expert in immunodeficiency genetics, awarded the Japan Prize in 2015.

  • Erik Van Den BergChairman, Independent Director
  • Neil Gallagher, MD, PhDIndependent Non-Executive Director
  • Claus Andersson, PhDSunstone Life Science Ventures
  • Thibaut RoulonBpifrance
  • Walter StockingerHadean Ventures
  • Ohad HammerPontifax
  • Rémi DrollerKurma Partners
  • Ward CapoenV-Bio Ventures

Get in touch with Step Pharma

15 rue Louis et Auguste Lumière, Technoparc du Pays-de-Gex, 01630 Saint-Genis-Pouilly, France.

Contact form